微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 2.51% | -10.99% | 57.86% | 93/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.59% | 15.22% | 57.43% | 93/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.01% | -0.98% | -51.44% | 93/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 2.08% | 0.48% | -26.24% | 88/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 2.82% | 18.99% | 104.35% | 95/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.38% | 10.4% | 35.29% | 96/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.02% | 2% | -50.72% | 92/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 2.07% | 23.95% | -12.66% | 98/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 2.37% | 5.33% | 89.6% | 92/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 1.25% | -37.19% | 25% | 102/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1% | 7.53% | -40.12% | 90/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 1.67% | 109.59% | -25.78% | 102/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 2.25% | 138.93% | 13.07% | 103/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 1.99% | 84.26% | 113.98% | 98/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 0.93% | 181.82% | 105.34% | 97/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | -17.42% | -646.08% | -201.38% | 130/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | -5.78% | -280.63% | -635.19% | 108/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 1.08% | -50.68% | 227.27% | 99/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 0.33% | -64.52% | -89.66% | 81/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 3.19% | -17.14% | -0.31% | 103/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 3.2% | 23.55% | 46.12% | 85/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 2.19% | 12.31% | 135.48% | 85/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 0.93% | -23.77% | -75.84% | 87/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 3.85% | -22.85% | 48.65% | 98/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 2.59% | -22.92% | 32.82% | 89/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 1.95% | -22% | 59.84% | 83/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.22% | 35.56% | -75.55% | 75/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 4.99% | -30.89% | 48.51% | 85/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 3.36% | -35.14% | 34.4% | 74/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 2.5% | -29.78% | 177.78% | 77/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.9% | -46.75% | -87.53% | 63/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 7.22% | -29.77% | 39.38% | 70/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 5.18% | -28.16% | 45.51% | 49/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 3.56% | -22.78% | 110.65% | 55/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 1.69% | -28.69% | -83.56% | 48/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 10.28% | 8.21% | 42.58% | 49/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 7.21% | -0.96% | 56.4% | 37/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 4.61% | -4.16% | 94.51% | 40/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 2.37% | 50.96% | -75.05% | 36/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |